# Constitutively Active Stat5b Expression in Dendritic Cells Enhances Treg-Mediated Elimination of Autoreactive CD8+ T Cells in Autoimmune Diabetes

**Authors:** Puregmaa Khongorzul, Farhan Ullah Khan, Daphnée Levasseur, Denis Gris, Abdelaziz Amrani

PMC · DOI: 10.3390/ijms27020794 · 2026-01-13

## TL;DR

A mutation in dendritic cells in diabetic mice improves Treg function, reducing harmful CD8+ T cells and preventing diabetes.

## Contribution

Constitutively active Stat5b in dendritic cells enhances Treg-mediated elimination of autoreactive CD8+ T cells in autoimmune diabetes.

## Key findings

- NOD.Stat5b-CA mice show expanded Treg populations and reduced CD8+ T cells in peripheral lymphoid organs.
- Tregs from NOD.Stat5b-CA mice exhibit increased activation markers and cytotoxic potential.
- CD8+ T cell reduction is mediated via Treg cytotoxic activity, including perforin and granzyme B expression.

## Abstract

In type 1 diabetes (T1D) in non-obese diabetic (NOD) mice, dendritic cells (DCs) exhibit a Stat5b mutation that impairs regulatory T cell (Tregs) numbers and suppressive function. To correct this defect, we generated transgenic NOD mice expressing constitutively active Stat5b (NOD.Stat5b-CA) in DCs, which conferred protection from diabetes that was associated with an expanded Treg population and a marked reduction in CD8+ T cell frequencies in secondary lymphoid organs. However, the phenotypic characteristics and underlying mechanisms to eliminate CD8+ T cells in NOD.Stat5b-CA mice are unknown. In this study, we found that the frequency of Tregs was significantly higher in the thymus and peripheral lymphoid organs of NOD.Stat5b-CA mice compared with NOD mice. Tregs in the peripheral lymphoid organs exhibited increased expression of activation markers CD69 and OX40, alongside reduced CD62L. We also found that CD8+ T cell frequencies were reduced in the peripheral organs but not in the thymus of NOD.Stat5b-CA mice, while CD4+ T cell frequencies remained unchanged across all organs. Furthermore, NOD.Stat5b-CA mice exhibited a reduced frequency of central Tregs (CD62Lhigh CD44low) and increased frequency of effector Tregs (CD62Llow CD44high) under steady-state conditions compared to NOD mice. Notably, Tregs from NOD.Stat5b-CA mice displayed enhanced cytotoxic activity, evidenced by increased expression of perforin, granzyme B, and Fas ligand, potentially mediating CD8+ T cell frequency reduction. Collectively, these findings highlight a novel role for Stat5b-CA.DC-educated Tregs in modulating immune responses by eliminating peripheral pathogenic CD8+ T cells via cytotoxic pathways, thereby contributing to immune regulation in NOD.Stat5b-CA mice.

## Linked entities

- **Genes:** STAT5B (signal transducer and activator of transcription 5B) [NCBI Gene 6777]
- **Proteins:** CD69 (CD69 molecule), TNFRSF4 (TNF receptor superfamily member 4), SELL (selectin L), CD44 (CD44 molecule (IN blood group)), PRF1 (perforin 1)
- **Diseases:** type 1 diabetes (MONDO:0005147)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Sell (selectin, lymphocyte) [NCBI Gene 20343] {aka CD62L, L-selectin, LAM-1, LECAM-1, LECAM1, Lnhr}, Cd69 (CD69 antigen) [NCBI Gene 12515] {aka 5830438K24Rik, AIM, VEA}, Stat5b (signal transducer and activator of transcription 5B) [NCBI Gene 20851], Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Tnfrsf4 (tumor necrosis factor receptor superfamily, member 4) [NCBI Gene 22163] {aka ACT35, CD134, Ly-70, Ox40, TXGP1L, Txgp1}, Gzmb (granzyme B) [NCBI Gene 14939] {aka CCP-1/C11, CCP1, Ctla-1, Ctla1, GZB}
- **Diseases:** NOD (MESH:D009765), diabetes (MESH:D003920), Autoimmune Diabetes (MESH:D003922)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12841221/full.md

---
Source: https://tomesphere.com/paper/PMC12841221